and IBM Partner for Personal Data Property Rights

Published on: 

Pharmaceutical Executive, the organization developing human rights and corollary sovereign laws in a decentralized manner on blockchains, announced it will use IBM’s Blockchain Platform technology for its global consent ledger. Using IBM’s platform, will give people control to manage consent, authorization, and commercial use of their personal information via a permissioned blockchain-based data marketplace.

Consumers can claim their human data rights via’s #My31 iPhone and Android app built on IBM Blockchain. Some capabilities include users can choose to share no information with third parties, or they may want to provide consent for use of their medical data for cancer research only. Users can also choose to lease their data to pharmaceutical companies or data aggregators but only upon receiving fair market compensation.